ATE419389T1 - Sak: modulation der zellproliferation zur krebsbehandlung - Google Patents

Sak: modulation der zellproliferation zur krebsbehandlung

Info

Publication number
ATE419389T1
ATE419389T1 AT02750377T AT02750377T ATE419389T1 AT E419389 T1 ATE419389 T1 AT E419389T1 AT 02750377 T AT02750377 T AT 02750377T AT 02750377 T AT02750377 T AT 02750377T AT E419389 T1 ATE419389 T1 AT E419389T1
Authority
AT
Austria
Prior art keywords
modulation
cellular proliferation
sak
nucleic acids
cell cycle
Prior art date
Application number
AT02750377T
Other languages
English (en)
Inventor
Susan Demo
Yasumichi Hitoshi
Yonchu Jenkins
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE419389T1 publication Critical patent/ATE419389T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02750377T 2001-08-01 2002-07-31 Sak: modulation der zellproliferation zur krebsbehandlung ATE419389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30963201P 2001-08-01 2001-08-01
US10/026,021 US7413870B2 (en) 2001-08-01 2001-12-21 SAK: modulation of cellular proliferation for treatment of cancer

Publications (1)

Publication Number Publication Date
ATE419389T1 true ATE419389T1 (de) 2009-01-15

Family

ID=26700612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02750377T ATE419389T1 (de) 2001-08-01 2002-07-31 Sak: modulation der zellproliferation zur krebsbehandlung

Country Status (7)

Country Link
US (1) US7413870B2 (de)
EP (1) EP1549760B1 (de)
AT (1) ATE419389T1 (de)
AU (1) AU2002318934A1 (de)
DE (1) DE60230684D1 (de)
ES (1) ES2320328T3 (de)
WO (1) WO2003012055A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
AU2002318374A1 (en) * 2001-06-21 2003-01-08 Baylor College Of Medicine Prediction, diagnosis and treatment of endocrine resistant breast cancer, using p38 mapk pathway
EP1687405A4 (de) * 2003-11-24 2007-10-31 Exelixis Inc Ttbks als modifikatoren des beta-catenin-wegs sowie verwendungsverfahren
EP1754052B1 (de) * 2004-06-03 2015-07-22 Phylogica Limited Modulatoren biochemischer eigenschaften
US8575070B2 (en) 2006-02-20 2013-11-05 Phylogica Limited Methods of constructing and screening libraries of peptide structures
CA2663545A1 (en) 2006-09-19 2008-03-27 Phylogica Limited Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
US8822409B2 (en) 2007-06-20 2014-09-02 Phylogica Limited Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
WO2009065232A1 (en) * 2007-11-20 2009-05-28 University Health Network Cancer diagnostic and therapeutic methods that target plk4/sak

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5589356A (en) * 1993-06-21 1996-12-31 Vanderbilt University Litigation of sidechain unprotected peptides via a masked glycoaldehyde ester and O,N-acyl rearrangement
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5650501A (en) 1994-06-02 1997-07-22 Mount Sinai Hospital Corporation Serine/threonine kinase and nucleic acids encoding same
US5959081A (en) * 1997-05-14 1999-09-28 The Board Of Trustees Of The University Of Arkansas Zinc binding LIM protein S2-6
US6569662B1 (en) 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
CA2402563A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
EP1549760B1 (de) 2008-12-31
EP1549760A2 (de) 2005-07-06
EP1549760A4 (de) 2006-04-26
ES2320328T3 (es) 2009-05-21
AU2002318934A8 (en) 2005-11-17
DE60230684D1 (de) 2009-02-12
US20030027756A1 (en) 2003-02-06
WO2003012055A3 (en) 2005-05-12
US7413870B2 (en) 2008-08-19
AU2002318934A1 (en) 2003-02-17
WO2003012055A2 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
WO2003094862A3 (en) tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS
IL174902A (en) Non-neutralized and multi-specific 3cd binders, nucleic acid sequence encoding them, process for their preparation, preparation, kit, vector, surrogate cell and their use
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
WO2007067730A3 (en) Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
WO2004019893A3 (en) Modulators of angiogenesis
CY1113096T1 (el) Αντισωματα της ip-10 και οι χρησεις αυτων
EA200870020A1 (ru) Человеческие моноклональные антитела против о8е
DK1240325T3 (da) IL-17 og IL-17R homologe polypeptider og terapeutisk anvendelse deraf
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
WO2004039955A3 (en) Modulators of angiogenesis and tumorigenesis
ATE526037T1 (de) Verfahren zum abtöten von tumorzellen mittels targeting von auf apoptotischen tumorzellen exponierten internen antigenen
FI20011664A7 (fi) Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
DE60230684D1 (de) Sak: modulation der zellproliferation zur krebsbehandlung
TW200635946A (en) Binding proteins specific for human matriptase
MXPA03010523A (es) Anticuerpos especificos para cd44v6.
WO2003088910A3 (en) Methods of assaying for cell cycle modulators
ATE514718T1 (de) Peptabody für krebsbehandlung
DE60133104D1 (de) Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren
WO2004020979A3 (en) Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
HUP0402327A2 (hu) Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása
WO2002078610A3 (en) Pak2: modulators of lymphocyte activation
WO2002085289A3 (en) Modulators of angiogenesis
WO2005069855A3 (en) Modulators of angiogenesis
WO2004038036A3 (en) Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties